Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine add-on prophylaxis in patients with migraine
IRCT20171230038142N21Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of memantine in migraine (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Pain severity, Mental health and 3 more. Started Aug 2019; status: completed.
02
Drugs
memantine
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT20171230038142N21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171230038142N21.